Image
Point of Care 101

The Pursuit of Hepatitis C Elimination

How the Pharmacist Can Make a Difference

Meeting Slides

Meeting Slides Part 2

Clinical Practice Guidelines

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C.

American Association for the Study of Liver Diseases/Infectious Diseases Society of America (2018).

Clinical Resources

A Guide to Comprehensive Hepatitis C Counseling and Testing.

Centers for Disease Control and Prevention.

Harm Reduction Coalition.

 

HEP Drug Interactions.

University of Liverpool (last reviewed May 2019).

Action and Advocacy

Center for Health Law and Policy Innovation (CHLPI) Harvard Law School

CHLPI advocates for legal, regulatory, and policy reforms to improve the health of underserved populations. It has played a pivotal role in removing Medicaid restrictions on HCV treatment.

Hepatitis C: State of Medicaid Access

CHLPI and National Viral Hepatitis Roundtable (NVHR)

Hepatitis Education Project (HEP)

HEP provides support, education, advocacy, and direct services for people affected by hepatitis, and works to raise hepatitis awareness among patients, medical providers, and the general public.

National Viral Hepatitis Roundtable (NVHR)

NVHR is a coalition working to eliminate hepatitis B and C in the United States. It offers practical online resources for practice management.

Substance Abuse and Mental Health Services Administration (SAMHSA): Locator Map US Department of Health and Human Services

SAMHSA provides an interactive national map that facilitates identification of local resources and services for substance use and mental health disorders.

Suggested Readings

Attitudes and potential barriers towards hepatitis C treatment in patients with and without HIV coinfection.

Allyn PR, et al. Int J STD AIDS. 2018;29(4):334-340.

Pharmacist engagement within a hepatitis C ambulatory care clinic in the era of a treatment revolution.

Gauthier TP, et al. J Am Pharm Assoc (2003). 2016;56(6):670-676.

A regional analysis of hepatitis C virus collaborative care with pharmacists in Indian health service facilities.

Geiger R, et al. J Prim Care Community Health. 2018;9:1-5.

Medical and behavioral approaches to engage people who inject drugs into care for hepatitis C virus infection.

Gonzalez SA, et al. Addict Disord Their Treat. 2017;16(2 suppl 1):S1-S23.

Pharmacist-initiated hepatitis C virus screening in a community pharmacy to increase awareness and link to care at the medical center.

Isho NY, et al. J Am Pharm Assoc (2003). 2017;57(suppl 3):S259-S264.

Hepatitis C point-of-care screening in retail pharmacies in the United States.

Kugelman M, et al. Gastroenterol Hepatol. 2017;13(2):98-104.

Optimizing hepatitis C virus treatment through pharmacist interventions: identification and management of drug-drug interactions.

Langness JA, et al. World J Gastroenterol. 2017;23(9):1618-1626.

HCV testing in NSP (needle and syringe provision) community pharmacies pilot (phase 1).

Verma S, Leeman D; London Joint Working Group. Published May 2018.

Implementation of a hepatitis C collaborative drug therapy management service in an HIV ambulatory care clinic.

Sorbera M, et al. Innov Pharm. 2018;9(1).

A bitter pill to swallow: why medication safety is critical in hepatitis C treatment.

Sullivan K, et al. P T. 2018;43(12):764-768.

Patient Resources

Hepatitis C Information Center

American Liver Foundation
The American Liver Foundation’s Hepatitis C Information Center website is a dedicated online information and resource center created in support of individuals impacted by HCV infection.

HepatitisC.net

HepatitisC.net is a website for people living with HCV that offers education, tools, and resources. Articles are written by people living with or cured of HCV, patient advocates, and medical providers.

Hepatitis C Questions and Answers for the Public

Centers for Disease Control and Prevention (CDC; last reviewed November 2018)
The CDC is a division within the US Department of Health and Human Services (DHHS), the principal agency for protecting the health of all Americans. This patient-directed website addresses basics across the HCV clinical continuum.

Activity
The Pursuit of Hepatitis C Elimination: How the Pharmacist Can Make a Difference

Part 1: The Pharmacists’ Role in HCV Testing and Counseling—Reaching Patients With the Greatest Need

Activity
The Pursuit of Hepatitis C Elimination: How the Pharmacist Can Make a Difference

Part 2: Understanding the Landscape of Current HCV Treatment

Relevant Resources

PrEP for Your Patients’ Needs

The PCPs Role in Preventing HIV

BRIDGE HCV

Building Bridges to Reach People Who Inject Drugs With the Goal to Eliminate HCV

Value-Based HIV Formularies

Optimizing Use of Clinical Evidence & Pharmacoeconomic Models in Managed Care

Targeting NASH

Advances in the Diagnosis and Treatment of Nonalcoholic Steatohepatitis

Hepatitis C is Curable

Got it? Treat it!

Real-World Issues in HIV Prevention & Treatment

The Critical Role of the Community Pharmacist

BLOCK HIV/HCV

Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships.

Evolving Models of HIV Care

Volume 1: Rapid ART Initiation: A New Addition to the HIV-Care Tool Box

The Nexus of NASH and Type 2 Diabetes Mellitus

The Emerging Role of the Diabetologist

Updates in HCV Screening and Treatment

Key Issues Impacting OB/GYN Practice

The Big Picture of IBD

An Interactive Experience Highlighting Recent Clinical Advances

Clinical Issues in Chronic Liver Disease

Hot Topics in HBV, HCV, and NASH

The Changing Landscape of IBD

Emerging Concepts in Patient Management

The Big (& Small) Picture of Nonalcoholic Steatohepatitis

Building Your Understanding to Combat a Growing Problem

Evolving Models of HIV Care

Volume II: Expanding Evidence for the Role of Rapid ART Initiation in HIV Practice

Assessing Your Patients for HCV and HIV

Why It Matters in OB/GYN Practice Today

HIV as a Chronic Disease

A Treater’s Guide to Optimizing Care in the Aging Patient with Comorbidities